Why Strategy (MSTR) stock is up after-hours after its latest $2.1 billion bitcoin buy
22 January 2026
1 min read

Why Strategy (MSTR) stock is up after-hours after its latest $2.1 billion bitcoin buy

New York, January 21, 2026, 17:47 EST — After-hours

  • After the bell, strategy shares climbed, following bitcoin’s stronger momentum.
  • A new SEC filing revealed additional bitcoin buys financed by selling shares.
  • Traders are focused on the company’s results and webcast scheduled for Feb. 5.

Strategy Inc shares climbed roughly 2.3% after hours Wednesday, closing at $163.81. The stock swung between $156.03 and $165.61 throughout the session, with volume hitting around 18.4 million shares.

This move is significant since Strategy acts as a high-beta stand-in for bitcoin, with the company relying heavily on capital markets to boost its holdings. That approach can amplify gains when bitcoin climbs, but it also risks deepening losses quickly when the token falls.

Financing sits at the core. Investors are closely monitoring if Strategy can continue offloading stock without hiccups—and at what price—while bitcoin’s rollercoaster volatility keeps pushing risk tolerance to the limit.

A filing on Tuesday revealed Strategy purchased 22,305 bitcoin between Jan. 12 and Jan. 19, spending $2.125 billion at an average price of $95,284 per coin, boosting its total holdings to 709,715. During that same window, the company raised roughly $2.125 billion through at-the-market (ATM) programs—mechanisms allowing firms to sell shares directly into the market—selling 10.4 million common shares alongside smaller amounts of two preferred stock issues. The filing puts Strategy’s total bitcoin acquisition cost at $53.92 billion, or $75,979 per coin. 1

Bitcoin climbed roughly 1.7% to $89,919, recovering from a low of $87,304 reached earlier today.

On Tuesday, billionaire Michael Saylor’s Strategy — formerly MicroStrategy — announced it had snapped up about $2.13 billion worth of bitcoin over eight days. The news didn’t help its stock, which dropped 7.4%, while bitcoin itself slid 3.6%. “Strategy is still buying Bitcoin because stopping would be as much a signal to the market as purchasing more,” said Nic Puckrin, analyst and co-founder of Coin Bureau. Earlier this month, Strategy reported an unrealized Q4 loss of $17.44 billion on its digital holdings. 2

The trade cuts both ways. Should bitcoin remain under pressure, the stock risks further losses, and investors might shy away from additional issuance—especially if the company leans more on preferred shares or other costly financing.

Strategy plans to release its fourth-quarter results after U.S. markets close on Thursday, Feb. 5, followed by a live video webinar at 5:00 p.m. Eastern to go over the details. Traders are keen to see if there’s any new information on bitcoin purchases or updates on how much fresh capital the company raises ahead of the release. 3

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
IRS shake-up hits days before 2026 tax season as Bisignano taps Hunter Biden whistleblowers
Previous Story

IRS shake-up hits days before 2026 tax season as Bisignano taps Hunter Biden whistleblowers

AST SpaceMobile stock drops after Blue Origin unveils TeraWave satellite network — what ASTS investors watch next
Next Story

AST SpaceMobile stock drops after Blue Origin unveils TeraWave satellite network — what ASTS investors watch next

Go toTop